AstraZeneca taps Korean researchers to explore oncology leads
This article was originally published in Scrip
Executive Summary
AstraZeneca has unveiled a new open innovation collaborative program for cancer research involving academic institutions in South Korea that it hopes will eventually reap dividends for its oncology pipeline.